Trial Profile
A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novartis
- 05 Nov 2010 New trial record.